← Back to Clinical Trials
Recruiting NCT06886841

NCT06886841 Parental Well-being After Childbirth in Switzerland

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06886841
Status Recruiting
Phase
Sponsor Laurent Gaucher
Condition Mental Health
Study Type OBSERVATIONAL
Enrollment 4,200 participants
Start Date 2025-03-17
Primary Completion 2025-08

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 4,200 participants in total. It began in 2025-03-17 with a primary completion date of 2025-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Improving maternal and child health is a global priority, with increasing emphasis on ensuring women and their families not only survive but also thrive after childbirth. While high-income countries like Switzerland provide strong antenatal and intrapartum care, the quality of postnatal care often lags behind, despite the critical physical, mental, and social needs of the postpartum period. Studies indicate high rates of mental distress, physical pain, and sexual discomfort among mothers, alongside a lack of research on the well-being of co-parents. The main question this cohort study aims to answer is: how do the health and well-being of mothers and co-parents evolve during the first year after childbirth? Participants will complete four online questionnaires: the first within the first few days after birth, followed by additional assessments at 2, 6, and 12 months postpartum. This comprehensive approach seeks to inform policy and improve evidence-based postnatal care practices, benefiting approximately 80,000 families annually in Switzerland.

Eligibility Criteria

Inclusion criteria: * Women who give birth in a participating maternity unit or birth center during the study period. * Partner of a participating women: the partner must be designated by the mother, live with her at the time of birth, and only one partner can be included per mother. * Gestational age at birth: ≥22+0 weeks and/or birthweight ≥500 grams * Age: Participants must be 14 years or older. * Language Proficiency: Participants must have sufficient proficiency in one of Switzerland's main official languages (German, French, Italian) or English to ensure accurate communication and comprehension of study materials. Exclusion Criteria: * Refusal to participate * Inability to provide informed consent

Contact & Investigator

Central Contact

Laurent GAUCHER, PhD

✉ laurent.gaucher@hesge.ch

📞 +41 22 558 68 96

Principal Investigator

Laurent Gaucher, RM, PhD

PRINCIPAL INVESTIGATOR

Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland.

Frequently Asked Questions

Who can join the NCT06886841 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, studying Mental Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06886841 currently recruiting?

Yes, NCT06886841 is actively recruiting participants. Contact the research team at laurent.gaucher@hesge.ch for enrollment information.

Where is the NCT06886841 trial being conducted?

This trial is being conducted at Geneva, Switzerland, Winterthur, Switzerland.

Who is sponsoring the NCT06886841 clinical trial?

NCT06886841 is sponsored by Laurent Gaucher. The principal investigator is Laurent Gaucher, RM, PhD at Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland.. The trial plans to enroll 4,200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology